Sharekhan's research report on Granules India
For Q2FY2024, Granules reported revenue growth of ~3% y-o-y/+20% q-o-q to Rs. 1,189 crore driven by strong growth of 27% YoY in its formulations revenue (~62% of sales) and pick up in the North America region which grew by 11% YoY to Rs 799 crs. Some of the delayed launches of the approved products, both in the U.S. and other geographies, will be launched in this and the coming quarters and would contribute to higher revenue and profitability. The company plans to spend Rs. 2,000 crore over the next five years to build a green chemistry plant at Kakinada, AP, which will enable it to be carbon zero in API manufacturing. An ambitious capex plan should help it to become a fully integrated player, which can bring benefits of operating leverage over medium to long term.
Outlook
The stock currently trades at attractive valuations of ~14.7x/12.4x its FY2024E/25E earnings vs. its peers trading at ~21.0x/17.1x their FY24E/FY25E EPS estimates. We maintain Buy with a revised PT of Rs. 417.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.